Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAGLN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KCNA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PSMB4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SERPINA3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HTR1E - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CTSB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DLL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NAGA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NDUFS3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GSS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NDUFS7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DNASE1L1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ALPL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EIF2B1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACOT8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPON1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
G6PC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ATP6V0D1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
APRT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on